Nuformix PLC (NFXN)

Currency in GBP
0.1950
-0.0450(-18.75%)
Closed·
NFXN Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
NFXN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.18200.2425
52 wk Range
0.04000.3650
Key Statistics
Bid/Ask
0.18 / 0.23
Prev. Close
0.24
Open
0.2
Day's Range
0.182-0.2425
52 wk Range
0.04-0.365
Volume
87.36M
Average Volume (3m)
54.15M
1-Year Change
336.36%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NFXN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Nuformix PLC Company Profile

Nuformix plc, together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. The company develops NXP001, which is in the Phase 1 stage for use in oncology supportive care; NXP002, which is in the pre-clinical stage for the treatment of idiopathic pulmonary fibrosis; and NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology. It has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.

Employees
3

Compare NFXN to Peers and Sector

Metrics to compare
NFXN
Peers
Sector
Relationship
P/E Ratio
−1.3x−5.3x−0.7x
PEG Ratio
0.00−0.130.00
Price/Book
5.9x3.3x2.6x
Price / LTM Sales
-2.9x3.4x
Upside (Analyst Target)
-58.1%36.2%
Fair Value Upside
Unlock5.8%4.1%Unlock

Earnings

Latest Release
May 02, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

NFXN Income Statement

People Also Watch

5.10
KDNC
+8.51%
0.050
ORCP
-13.91%
3.16
ALRT
+10.49%
0.0312
UKOGa
-5.45%
0.250
ROCKR
+4.17%

FAQ

What Stock Exchange Does Nuformix Trade On?

Nuformix is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for Nuformix?

The stock symbol for Nuformix is "NFXN."

What Is the Nuformix Market Cap?

As of today, Nuformix market cap is 3.89M.

What Is Nuformix's Earnings Per Share (TTM)?

The Nuformix EPS (TTM) is -0.00.

When Is the Next Nuformix Earnings Date?

Nuformix will release its next earnings report on 02 Dec 2025.

From a Technical Analysis Perspective, Is NFXN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Nuformix Stock Split?

Nuformix has split 0 times.

How Many Employees Does Nuformix Have?

Nuformix has 3 employees.

What is the current trading status of Nuformix (NFXN)?

As of 06 Oct 2025, Nuformix (NFXN) is trading at a price of 0.1950, with a previous close of 0.24. The stock has fluctuated within a day range of 0.1820 to 0.2425, while its 52-week range spans from 0.0400 to 0.3650.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.